Aspira Pathlab & Diagnostics Limited (BOM: 540788)

Market Cap	438.28M
Revenue (ttm)	152.38M
Net Income (ttm)	-19.09M
Shares Out	10.29M
EPS (ttm)	-1.89
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,419
Open	42.15
Previous Close	42.07
Day's Range	42.15 - 43.90
52-Week Range	25.00 - 50.11
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About Aspira Pathlab & Diagnostics

Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers primarily in India. It offers biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigation services. The company was formerly known as Utkal Soap Products Limited and changed its name to Aspira Pathlab & Diagnostics Limited in November 2016. Aspira Pathlab & Diagnostics Limited was incorporated in 1973 and is based in Mumbai, India.

• Industry: Medical Laboratories
• Founded: 1973
• Employees: 115
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540788

Financial Performance

In 2023, Aspira Pathlab & Diagnostics's revenue was 132.05 million, a decrease of -8.66% compared to the previous year's 144.57 million. Losses were -26.72 million, 2912.6% more than in 2022.